Free tool
Cell therapy stocks
We cover 11 companies grouped under the Cell therapy theme. The median market value in the group is $43.76M. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −43.0% to −9.9% across the middle 80 percent of the group, with a median of −20.8%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
11 of 86 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 7776.T | CellSeed Inc. | $57.40M | Micro cap | −47.75% |
| 4896.T | K Pharma,Inc. | $56.46M | Micro cap | +15.50% |
| ALA.AX | Arovella Therapeutics Limited | $53.07M | Micro cap | −29.89% |
| 7096.T | StemCell Institute Inc. | $47.97M | Micro cap | −20.83% |
| 2370.T | MEDINET Co., Ltd. | $45.96M | Micro cap | −31.58% |
| 3750.T | ADR Biomedical Holdings Inc. | $43.76M | Micro cap | −14.54% |
| 4880.T | CellSource Co., Ltd. | $42.67M | Micro cap | −43.02% |
| 4893.T | Noile-Immune Biotech Inc. | $40.26M | Micro cap | −18.68% |
| 4892.T | Cyfuse Biomedical K.K. | $35.91M | Micro cap | −9.90% |
| CMB.AX | Cambium Bio Limited | $8.90M | Micro cap | −10.64% |
| 1AD.AX | AdAlta Limited | $6.94M | Micro cap | −25.00% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.